Main therapeutic options for symptomatic patients with mixed, hepatitis C virus (HCV)-related, cryoglobulinemia.
| Category . | Activity . |
|---|---|
| Corticosteroids (low-, high-dose) | Anti-inflammatory, immunosuppressive |
| Cyclophosphamide | Immunosuppressive |
| Plasma-exchange | Removal of circulating immune complexes |
| Interferon + Ribavirin | Antiviral (HCV eradication) |
| Anti-CD20 antibody (rituximab) | Selective suppression of B-cell clone |
| Category . | Activity . |
|---|---|
| Corticosteroids (low-, high-dose) | Anti-inflammatory, immunosuppressive |
| Cyclophosphamide | Immunosuppressive |
| Plasma-exchange | Removal of circulating immune complexes |
| Interferon + Ribavirin | Antiviral (HCV eradication) |
| Anti-CD20 antibody (rituximab) | Selective suppression of B-cell clone |